Senomyx (SNMX) Receiving Somewhat Positive Press Coverage, Analysis Shows

Press coverage about Senomyx (NASDAQ:SNMX) has trended somewhat positive this week, according to Accern. Accern identifies negative and positive media coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Senomyx earned a news impact score of 0.11 on Accern’s scale. Accern also assigned media coverage about the specialty chemicals company an impact score of 47.0195238647928 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

NASDAQ:SNMX traded up $0.10 during mid-day trading on Friday, hitting $1.42. The stock had a trading volume of 361,439 shares, compared to its average volume of 106,035. The stock has a market cap of $63.76 million, a price-to-earnings ratio of -47.33 and a beta of 1.42. Senomyx has a twelve month low of $0.56 and a twelve month high of $1.71.

Senomyx (NASDAQ:SNMX) last issued its earnings results on Thursday, April 26th. The specialty chemicals company reported ($0.08) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.07) by ($0.01). The firm had revenue of $3.11 million during the quarter. Senomyx had a negative net margin of 5.66% and a negative return on equity of 10.75%.

Separately, ValuEngine raised shares of Senomyx from a “sell” rating to a “hold” rating in a report on Wednesday, May 2nd.

About Senomyx

Senomyx, Inc discovers, develops, and commercializes flavor ingredients and natural high intensity sweeteners primarily for the packaged food, beverage, and ingredient supply industries in the United States. The company develops and/or commercializes sweet, savory and salt flavor ingredients, bitter blockers and cooling agents.

Insider Buying and Selling by Quarter for Senomyx (NASDAQ:SNMX)

Receive News & Ratings for Senomyx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senomyx and related companies with's FREE daily email newsletter.

Leave a Reply